Ascendis Pharma A/S

ASNDNasdaq Denmark Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$15.603 B

$237.59 +0.37%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

61,977,408

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#24ViatrisVTRS$19.6B
#25Jazz PharmaceuticalsJAZZ$15.7B
#26Ascendis Pharma A/SASND$15.6B
#27Summit TherapeuticsSMMT$13.5B
#28BridgeBio PharmaBBIO$13.0B

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Ascendis Pharma A/S, worth $492.7K. Grants and option exercises are excluded.

Jean Jacques Bienaime$492.7K
2,000 shares at $246.33 on 14 Aug 2026 · filed 18 Aug 2026

What if Ascendis Pharma A/S were worth as much as…

Open the what-if tool →

Gold $30.3T

$460,979.75

Per share 1,940× higher

Bitcoin $1.72T

$26,187.27

Per share 110× higher

Nvidia $5.48T

$83,441.21

Per share 351× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Ascendis Pharma A/S are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.